Curated GI articles September 2nd, 2022: Gastro Health acquires Virginia practice | Vibrating pill gets FDA nod | GI robot at hospital
Curated GI articles September 2nd, 2022:
Gastro Health acquires Virginia practice | Vibrating pill gets FDA nod | GI robot at hospital
Gastro Health Finalizes Partnership with Charlottesville Gastroenterology Associates (Gastro Health)
Charlottesville Gastroenterology Associates is joining with six physicians and four advanced practice providers. This will be Gastro Health’s sixth partnership within the state since late 2019.
Bill & Melinda Gates Foundation supports Bactolife with $5M capital in its fight against Gastrointestinal infections (Tech Funding News)
The company will use the funds to accelerate its technology platform’s impact to develop Binding Proteins, a novel biologic solution to reduce the risk of gut infections.
GI Outlook roundup: Leadership, diversity, staffer retention (Healio)
Topics new to 2022 include the importance of diversity, equity and inclusion in practice, tips for being a great boss, succession planning and more.
Value-Based Physician Revenue Still the Exception, Not Norm: Report (Medscape)
“Value-based” contracts still generate a low percentage of revenue for physician groups, according to the latest report by the Medical Group Management Association (MGMA).
The Next Generation GI Physicians are Ready (and they are excited about the future) (Gastro Broadcast)
Dr. Naresh Gunaratnam interviews Dr. Justin Forde about what GI fellows are focused on and what innovations they may bring to the organizations they join.
Vibrant Gastro passes vibrating constipation pill through FDA review (Fierce Biotech)
Vibrant Gastro’s vibrating capsule aims to resynchronize the biological clock via the gastrointestinal system.
What role does social media have in GI? (MDedge)
Dr. Stephen Chris Pappas and Dr. Mohammad Bilal discuss the risks and benefits of social media for the practicing gastroenterologist.
Not the Usual Suspects: Don’t Overlook NAFLD in Lean Patients (Medscape)
The article highlights why it’s important for clinicians not to overlook NAFLD in their lean patients, how to identify them, and what interventions might prove most useful in treating them.
Biomerica Plans Launch of InFoods® IBS Test; Names Robert Carlson as Chief Commercial Officer (Globe Newswire)
Biomerica has received significant interest from Gastroenterology physicians who would like to order the InFoods IBS test for their patients immediately.
Brigham and Women’s adds gastrointestinal robot (Becker’s GI & Endoscopy)
Boston-based Brigham and Women’s Hospital is adding EndoQuest’s surgical robot capable of providing minimally-invasive gastrointestinal surgery using trans-oral or trans-anal methods.
Earlier CRC screening with colonoscopy, FIT cost-effective ‘irrespective of BMI’ (Healio)
Regardless of patient sex or BMI, initiating CRC screening with colonoscopy at age 45 years or with fecal immunochemical testing at age 40 years was cost-effective, according to new research.
High-quality Studies of Artificial Intelligence in Colonoscopy Illuminate a Next Important Step (AGA)
This issue of Gastroenterology focuses on the relevance of adenoma per colonoscopy (APC) as a novel endpoint in AI-related research.
Newest Digital Health Programs Address Digestive Disease Management (Healthcare IT Today)
There are smartphone apps for tracking everything, but gut health has largely been left in the digital dust. Bill Snyder (CEO of Vivante Health) highlights how that’s changing.
Exclude or Expose? The Paradox of Conceptually Opposite Treatments for Irritable Bowel Syndrome (Medscape)
The review addresses the paradox of conceptually opposite exclusion diets and exposure-based CBT for IBS.
Ergonomics in Endoscopy (ASGE)
In this podcast, Amandeep Shergill, MD, MS and Jonathan Buscaglia MD, FASGE discuss ergonomics in endoscopy.
COVID patients with GI symptoms experience worse in-hospital complications (AGA)
Older age, higher comorbidity scores and use of PPI and H2RA are associated with poor outcomes in these patients.
Takeda ends microbiome alliance with Finch Therapeutics after pipeline review (Medcity News)
The agreement termination means that two preclinical microbiome therapy candidates for inflammatory bowel disease will now return to Finch Therapeutics.
10 gastroenterologists to know (Becker’s GI & Endoscopy)
The list compiled by Becker’s Healthcare highlights 10 physicians who specialize in gastroenterology.
More Hot headlines in GI
Reassuring Data on NSAIDs in IBD Flares (Medscape)
Nonalcoholic Steatohepatitis: Identifying High-Risk Patients (GI & Endoscopy News)
Videos: Interviews with GI Leaders (NextServices)